JP2019077664A - カロテノイド組成物を含有する脳機能低下抑制剤または脳機能低下予防剤 - Google Patents

カロテノイド組成物を含有する脳機能低下抑制剤または脳機能低下予防剤 Download PDF

Info

Publication number
JP2019077664A
JP2019077664A JP2017208154A JP2017208154A JP2019077664A JP 2019077664 A JP2019077664 A JP 2019077664A JP 2017208154 A JP2017208154 A JP 2017208154A JP 2017208154 A JP2017208154 A JP 2017208154A JP 2019077664 A JP2019077664 A JP 2019077664A
Authority
JP
Japan
Prior art keywords
carotenoid
mass
composition
adonixanthin
astaxanthin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017208154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019077664A5 (cg-RX-API-DMAC7.html
Inventor
卓 石橋
Taku Ishibashi
卓 石橋
雅浩 林
Masahiro Hayashi
雅浩 林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eneos Corp
Original Assignee
JX Nippon Oil and Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JX Nippon Oil and Energy Corp filed Critical JX Nippon Oil and Energy Corp
Priority to JP2017208154A priority Critical patent/JP2019077664A/ja
Priority to US16/756,199 priority patent/US20210186895A1/en
Priority to CA3079373A priority patent/CA3079373A1/en
Priority to PCT/JP2018/020051 priority patent/WO2019082430A1/ja
Publication of JP2019077664A publication Critical patent/JP2019077664A/ja
Publication of JP2019077664A5 publication Critical patent/JP2019077664A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/045—Organic compounds containing nitrogen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2017208154A 2017-10-27 2017-10-27 カロテノイド組成物を含有する脳機能低下抑制剤または脳機能低下予防剤 Pending JP2019077664A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2017208154A JP2019077664A (ja) 2017-10-27 2017-10-27 カロテノイド組成物を含有する脳機能低下抑制剤または脳機能低下予防剤
US16/756,199 US20210186895A1 (en) 2017-10-27 2018-05-24 Cerebral hypofunction inhibitor or cerebral hypofunction prophylactic agent containing carotenoid composition
CA3079373A CA3079373A1 (en) 2017-10-27 2018-05-24 Cerebral hypofunction inhibitor or cerebral hypofunction prophylactic agent containing carotenoid composition
PCT/JP2018/020051 WO2019082430A1 (ja) 2017-10-27 2018-05-24 カロテノイド組成物を含有する脳機能低下抑制剤または脳機能低下予防剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017208154A JP2019077664A (ja) 2017-10-27 2017-10-27 カロテノイド組成物を含有する脳機能低下抑制剤または脳機能低下予防剤

Publications (2)

Publication Number Publication Date
JP2019077664A true JP2019077664A (ja) 2019-05-23
JP2019077664A5 JP2019077664A5 (cg-RX-API-DMAC7.html) 2020-11-12

Family

ID=66247237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017208154A Pending JP2019077664A (ja) 2017-10-27 2017-10-27 カロテノイド組成物を含有する脳機能低下抑制剤または脳機能低下予防剤

Country Status (4)

Country Link
US (1) US20210186895A1 (cg-RX-API-DMAC7.html)
JP (1) JP2019077664A (cg-RX-API-DMAC7.html)
CA (1) CA3079373A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019082430A1 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020095881A1 (ja) * 2018-11-05 2020-05-14 Ｊｘｔｇエネルギー株式会社 カロテノイドの血中滞留増加用組成物
WO2021045138A1 (ja) * 2019-09-04 2021-03-11 Ｅｎｅｏｓ株式会社 過敏性腸症候群の改善のための組成物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001002569A (ja) * 1999-06-18 2001-01-09 Itano Refrigerated Food Co Ltd 記憶力改善組成物
JP2007126455A (ja) * 2005-10-07 2007-05-24 Fuji Chem Ind Co Ltd 脳機能障害の改善剤
JP2012025712A (ja) * 2010-07-27 2012-02-09 Jx Nippon Oil & Energy Corp 抗不安組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6218624B2 (ja) * 2014-01-30 2017-10-25 Ｊｘｔｇエネルギー株式会社 虚血性疾患を予防するための薬剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001002569A (ja) * 1999-06-18 2001-01-09 Itano Refrigerated Food Co Ltd 記憶力改善組成物
JP2007126455A (ja) * 2005-10-07 2007-05-24 Fuji Chem Ind Co Ltd 脳機能障害の改善剤
JP2012025712A (ja) * 2010-07-27 2012-02-09 Jx Nippon Oil & Energy Corp 抗不安組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KATAGIRI,M. ET AL.: "Effects of astaxanthin-rich Haematococcus pluvialis extract on cognitive function: a randomised, dou", J.CLIN.BIOCHEM.NUTR., vol. 51, no. 2, JPN6018031874, 2012, pages 102 - 107, XP055597526, ISSN: 0004752642, DOI: 10.3164/jcbn.D-11-00017 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020095881A1 (ja) * 2018-11-05 2020-05-14 Ｊｘｔｇエネルギー株式会社 カロテノイドの血中滞留増加用組成物
WO2021045138A1 (ja) * 2019-09-04 2021-03-11 Ｅｎｅｏｓ株式会社 過敏性腸症候群の改善のための組成物

Also Published As

Publication number Publication date
US20210186895A1 (en) 2021-06-24
CA3079373A1 (en) 2019-05-02
WO2019082430A1 (ja) 2019-05-02

Similar Documents

Publication Publication Date Title
US6265450B1 (en) Anti-stress composition
EP1283038B1 (en) Compositions normalizing circadian rhythm
KR20080030633A (ko) 스트레스의 치료 또는 처치방법
AU2003282829B2 (en) Antioxidative Compositions
EP2691086A1 (en) Compositions for the treatment of neurologic disorders
CN100586297C (zh) 抗牙周病菌组合物
KR102135195B1 (ko) 테트라제노코커스 할로필러스를 포함하는 베체트병 또는 헤르페스 바이러스 감염증의 예방 또는 치료용 조성물
US7270840B2 (en) Antioxidative compositions
WO2019082430A1 (ja) カロテノイド組成物を含有する脳機能低下抑制剤または脳機能低下予防剤
TW202308605A (zh) 用於炎症性腸疾病之預防或改善之組合物、以及用於腸內細菌叢調節之組合物
WO2004112510A1 (ja) 運動生理機能向上剤
CN109069534B (zh) 认知功能改善剂
WO2002094253A1 (en) Agents for relieving eye controlling function error
KR101658403B1 (ko) 천연 당 시럽 및 그 제조 방법
KR100496524B1 (ko) 숙취해소용 조성물
CN110691592A (zh) 脑功能改善用组合物
JP2009102276A (ja) 抗糖尿病剤
JP2018095580A (ja) 抗不安用組成物
KR102191588B1 (ko) 겐티아나 루테아 추출물 또는 이로부터 분리된 화합물을 유효성분으로 포함하는 인지 기능 장애 예방 또는 치료용 조성물
US12364730B2 (en) Composition comprising oil palm phenolics for use in the treatment and prevention of colon diseases and for promoting and maintaining gut and general health
KR100520985B1 (ko) 아스타잔틴 및 아스파라긴산을 함유하는 숙취해소제
KR100540498B1 (ko) 아스타잔틴 및 아스파라긴산을 함유하는 숙취해소제
KR102214565B1 (ko) 프로텍틴 dx을 포함하는 숙취해소용 조성물
US20230293619A1 (en) Method for increasing melatonin in subject and regulating expression of tph gene, ddc gene, aanat gene, and asmt gene by using longan flower extract
US20190388491A1 (en) Anti-fatigue food composition and anti-fatigue agent

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20171116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200918

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200918

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211012

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220419